Annual Operating Expenses
$132.28 M
+$8.74 M+7.07%
31 December 2023
Summary:
Prelude Therapeutics Incorporated annual total operating expenses is currently $132.28 million, with the most recent change of +$8.74 million (+7.07%) on 31 December 2023. During the last 3 years, it has risen by +$73.51 million (+125.10%). PRLD annual operating expenses is now at all-time high.PRLD Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$37.38 M
+$212.00 K+0.57%
30 September 2024
Summary:
Prelude Therapeutics Incorporated quarterly total operating expenses is currently $37.38 million, with the most recent change of +$212.00 thousand (+0.57%) on 30 September 2024. Over the past year, it has increased by +$3.99 million (+11.95%). PRLD quarterly operating expenses is now -0.01% below its all-time high of $37.38 million, reached on 31 December 2023.PRLD Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRLD Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.1% | +11.9% |
| 3 y3 years | +125.1% | +21.2% |
| 5 y5 years | +783.3% | +442.9% |
PRLD Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +125.1% | -0.0% | +28.4% |
| 5 y | 5 years | at high | +783.3% | -0.0% | +442.9% |
| alltime | all time | at high | +783.3% | -0.0% | +442.9% |
Prelude Therapeutics Incorporated Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $37.38 M(+0.6%) |
| June 2024 | - | $37.16 M(+8.2%) |
| Mar 2024 | - | $34.34 M(-8.1%) |
| Dec 2023 | $132.28 M(+7.1%) | $37.38 M(+12.0%) |
| Sept 2023 | - | $33.38 M(+3.0%) |
| June 2023 | - | $32.40 M(+11.3%) |
| Mar 2023 | - | $29.11 M(-12.8%) |
| Dec 2022 | $123.54 M(+8.6%) | $33.38 M(+9.8%) |
| Sept 2022 | - | $30.41 M(+3.2%) |
| June 2022 | - | $29.46 M(-2.7%) |
| Mar 2022 | - | $30.29 M(-8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $113.73 M(+93.5%) | $33.01 M(+7.1%) |
| Sept 2021 | - | $30.84 M(+10.4%) |
| June 2021 | - | $27.92 M(+27.1%) |
| Mar 2021 | - | $21.97 M(+13.0%) |
| Dec 2020 | $58.76 M(+109.1%) | $19.45 M(+7.2%) |
| Sept 2020 | - | $18.14 M(+58.7%) |
| June 2020 | - | $11.44 M(+17.4%) |
| Mar 2020 | - | $9.74 M(-3.5%) |
| Dec 2019 | $28.11 M(+87.7%) | $10.10 M(+46.6%) |
| Sept 2019 | - | $6.88 M |
| Dec 2018 | $14.97 M | - |
FAQ
- What is Prelude Therapeutics Incorporated annual total operating expenses?
- What is the all time high annual operating expenses for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual operating expenses year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly operating expenses year-on-year change?
What is Prelude Therapeutics Incorporated annual total operating expenses?
The current annual operating expenses of PRLD is $132.28 M
What is the all time high annual operating expenses for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual total operating expenses is $132.28 M
What is Prelude Therapeutics Incorporated annual operating expenses year-on-year change?
Over the past year, PRLD annual total operating expenses has changed by +$8.74 M (+7.07%)
What is Prelude Therapeutics Incorporated quarterly total operating expenses?
The current quarterly operating expenses of PRLD is $37.38 M
What is the all time high quarterly operating expenses for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly total operating expenses is $37.38 M
What is Prelude Therapeutics Incorporated quarterly operating expenses year-on-year change?
Over the past year, PRLD quarterly total operating expenses has changed by +$3.99 M (+11.95%)